Indicative Announcement on Restricted Exercise Period for the Initial Grant of Stock Options under the 2022 Restricted Share and Stock Option Incentive Plan
Securities code: 600566 Securities abbreviation: Jichuan Pharmaceutical Announcement number: 2026-060
Hubei Jichuan Pharmaceutical Co., Ltd.
About the 2022 Restricted Stock and Stock Option Incentive Plan
Indicative announcement on the restricted exercise period of stock options granted for the first time
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
In accordance with the "Measures for the Administration of Equity Incentives of Listed Companies", "Self-Discipline Supervision Guidelines for Listed Companies of the Shanghai Stock Exchange No. 2 - Business Management", "Hubei Jichuan Pharmaceutical Co., Ltd. 2022 Restricted Stock and Stock Option Incentive Plan" and the relevant provisions of China Securities Depository and Clearing Co., Ltd. Shanghai Branch on the autonomous exercise of stock options, and in conjunction with the 2026 semi-annual report disclosure plan of Hubei Jichuan Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), the company's 2022 semi-annual report disclosure plan is now The annual restricted stock and stock option incentive plan imposes restrictions on the independent exercise time of the stock options first granted. The details are as follows:
The actual exercise period for the first exercise period of stock options granted under the company’s 2022 restricted stock and stock option incentive plan (option code: 1000000228) is from October 15, 2025 to September 7, 2026.
The restricted exercise period is from August 14, 2026 to August 28, 2026. During this period, all incentive objects will be restricted from exercising their options.
The company will promptly apply to the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. to handle matters related to restricted exercise in accordance with relevant regulations.
Announcement is hereby made.
Board of Directors of Hubei Jichuan Pharmaceutical Co., Ltd.
August 6, 2026